483 related articles for article (PubMed ID: 20117462)
1. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U
J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462
[TBL] [Abstract][Full Text] [Related]
2. Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation.
Adam O; Theobald K; Lavall D; Grube M; Kroemer HK; Ameling S; Schäfers HJ; Böhm M; Laufs U
J Mol Cell Cardiol; 2011 Apr; 50(4):678-85. PubMed ID: 21215756
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
[TBL] [Abstract][Full Text] [Related]
4. Rac1 and connective tissue growth factor. The missing link between atrial remodeling and the pathogenesis of atrial fibrillation?
Liao JK
J Am Coll Cardiol; 2010 Feb; 55(5):481-2. PubMed ID: 20117463
[No Abstract] [Full Text] [Related]
5. Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.
Lavall D; Schuster P; Jacobs N; Kazakov A; Böhm M; Laufs U
J Biol Chem; 2017 May; 292(18):7542-7553. PubMed ID: 28320863
[TBL] [Abstract][Full Text] [Related]
6. Role of Rac1 GTPase activation in atrial fibrillation.
Adam O; Frost G; Custodis F; Sussman MA; Schäfers HJ; Böhm M; Laufs U
J Am Coll Cardiol; 2007 Jul; 50(4):359-67. PubMed ID: 17659204
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-21 in the pathogenesis of atrial fibrosis.
Adam O; Löhfelm B; Thum T; Gupta SK; Puhl SL; Schäfers HJ; Böhm M; Laufs U
Basic Res Cardiol; 2012 Sep; 107(5):278. PubMed ID: 22760500
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling.
Tsai CT; Lai LP; Kuo KT; Hwang JJ; Hsieh CS; Hsu KL; Tseng CD; Tseng YZ; Chiang FT; Lin JL
Circulation; 2008 Jan; 117(3):344-55. PubMed ID: 18172037
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin signals through Rac1 determine the localization of connexin 43 in cardiac myocytes.
Matsuda T; Fujio Y; Nariai T; Ito T; Yamane M; Takatani T; Takahashi K; Azuma J
J Mol Cell Cardiol; 2006 Apr; 40(4):495-502. PubMed ID: 16515795
[TBL] [Abstract][Full Text] [Related]
10. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
Lavall D; Selzer C; Schuster P; Lenski M; Adam O; Schäfers HJ; Böhm M; Laufs U
J Biol Chem; 2014 Mar; 289(10):6656-6668. PubMed ID: 24469458
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II activates signal transducers and activators of transcription 3 via Rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease.
Xue XD; Huang JH; Wang HS
Cell Biochem Biophys; 2015 Jan; 71(1):205-13. PubMed ID: 25151145
[TBL] [Abstract][Full Text] [Related]
12. The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling.
Lavall D; Jacobs N; Mahfoud F; Kolkhof P; Böhm M; Laufs U
Biochem Pharmacol; 2019 Oct; 168():173-183. PubMed ID: 31283930
[TBL] [Abstract][Full Text] [Related]
13. miR‑132 in atrial fibrillation directly targets connective tissue growth factor.
Qiao G; Xia D; Cheng Z; Zhang G
Mol Med Rep; 2017 Oct; 16(4):4143-4150. PubMed ID: 28731126
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.
Li Y; Jian Z; Yang ZY; Chen L; Wang XF; Ma RY; Xiao YB
Cardiology; 2013; 124(4):233-40. PubMed ID: 23571482
[TBL] [Abstract][Full Text] [Related]
15. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
Adam O; Zimmer C; Hanke N; Hartmann RW; Klemmer B; Böhm M; Laufs U
J Mol Cell Cardiol; 2015 Aug; 85():140-50. PubMed ID: 26047574
[TBL] [Abstract][Full Text] [Related]
17. Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo.
Chilukoti RK; Mostertz J; Bukowska A; Aderkast C; Felix SB; Busch M; Völker U; Goette A; Wolke C; Homuth G; Lendeckel U
Int J Cardiol; 2013 Oct; 168(3):2100-8. PubMed ID: 23414741
[TBL] [Abstract][Full Text] [Related]
18. The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
Liu LJ; Yao FJ; Lu GH; Xu CG; Xu Z; Tang K; Cheng YJ; Gao XR; Wu SH
PLoS One; 2016; 11(9):e0161625. PubMed ID: 27611832
[TBL] [Abstract][Full Text] [Related]
19. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling.
Reil JC; Hohl M; Oberhofer M; Kazakov A; Kaestner L; Mueller P; Adam O; Maack C; Lipp P; Mewis C; Allessie M; Laufs U; Böhm M; Neuberger HR
Cardiovasc Res; 2010 Aug; 87(3):485-93. PubMed ID: 20211865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
